Participants 243 273 3
apparently healthy individuals
Participants 599 652 5
warfarin in survivors of acute myocardial infarction.
Participants 653 863 8
Patients aged 75 years or less were randomized in a double-blind, placebo-controlled study to test whether long-term treatment with warfarin reduces the risk of death, reinfarction, and thromboembolic morbidity
Participants 865 943 5
A total of 1918 patients were screened for participation; 1214 were recruited.
